2 employees
Immunservice GmbH uses highly effective and extremely well tolerated immune hormones to develop drugs according to biomimetic
2006
Immunservice raised undisclosed on February 18, 2015
Investors: High-Tech Gründerfonds
Immunservice raised undisclosed on January 21, 2008